Report - CHEMIOTERAPIA I RZUTU: IP vs DOSE DENSE · elderly patients with advanced ovarian cancer. A Multicenter Italian Trial in Ovarian Cancer (MITO-5) study. Crit Rev Oncol Hematol 2008

Please pass captcha verification before submit form